Halozyme Therapeutics shares owned by RidgeWorth Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by RidgeWorth Capital Management
from 13F filings
Historical chart of RidgeWorth Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by RidgeWorth Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by RidgeWorth Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $21k | 436 | 47.81 |
| 2024-09-30 | $43k | 757 | 57.24 |
| 2024-06-30 | $40k | 757 | 52.36 |
| 2024-03-31 | $31k | 750 | 40.68 |
| 2023-12-31 | $28k | 750 | 36.96 |
| 2023-09-30 | $29k | 750 | 38.20 |
| 2023-06-30 | $27k | 750 | 36.07 |
| 2023-03-31 | $29k | 750 | 38.19 |
| 2022-12-31 | $43k | 750 | 56.90 |
| 2017-12-31 | $981k | 48k | 20.27 |
| 2014-06-30 | $87k | 8.8k | 9.86 |
More positions owned by RidgeWorth Capital Management
View all positions for RidgeWorth Capital Management